Not FDA-approvedNeuropeptide

DSIP

DSIP (Delta Sleep Inducing Peptide), also known as emideltide, is a peptide comprised of a short chain of 9 amino acids.

Also known as Delta sleep-inducing peptide, emideltide

US statusNot FDA-approved
ClassNeuropeptide
RouteSubcutaneous
References2 cited

What is DSIP?

DSIP (Delta Sleep Inducing Peptide), also known as emideltide, is a peptide comprised of a short chain of 9 amino acids. Its primary research application is in inducing deep sleep, which is characterized by delta waves seen on an electroencephalogram (EEG). It was first discovered in the brain of rabbits during sleep. Similar to all other available peptides, it is synthesized (produced in a laboratory), and not derived from animals.

How Does DSIP Work?

DSIP appears to cross into the brain and CSF through active transport, where it may modulate neural activity in a state-dependent way — meaning its effects on sleep and EEG patterns can shift based on the individual’s baseline physiology. It likely influences hypothalamic–pituitary hormones, and it seems to trigger indirect opioid-like effects through met-enkephalin release. Once active, the peptide is rapidly broken down by brain and CSF peptidases, giving it a systemic clearance window of only a few minutes.

What is DSIP Used for?

DSIP is not currently approved as a prescription medication, but it has been studied in preclinical research. Areas of interest include:

  • Insomnia: Early research focused on the effects of DSIP in inducing deep sleep, and it is currently being investigated for that effect.
  • Withdrawal symptoms (alcohol and opioids): Due to its indirect effects on the opioid system, DSIP is thought to be able to lessen the withdrawal symptoms experienced following alcohol and opioid cessation. DSIP is not thought to be addictive because it only indirectly activates the opioid system, but this effect is still being investigated to determine whether it is sufficient to reduce the adverse symptoms of withdrawal.
  • Chronic pain syndromes: Similarly, its effects on the endogenous opioid system are thought to contribute to relief in people suffering from chronic pain syndrome.

Side Effects of DSIP

DSIP appears to be fairly well tolerated. Side effects may include mild heart rate variability, but this side effect is not well-documented.

DSIP Dosing Protocol (for Research)

While a dosing protocol has not been definitively determined by researchers, independent researchers report that DSIP is most effective when administered below the skin by injection (subcutaneous injection). One common research/educational dosing protocol is the following:

PhaseDose & frequency
Weeks 1-20.2 mg (200 mcg) 30-60 minutes before bed
Weeks 3 and beyond0.5 mg (500 mcg) 30-60 minutes before bed

Shown for education. A licensed clinician should set any actual dose. Compare protocols across peptides in the peptide dosage chart.

Common questions about DSIP

What is DSIP?

DSIP (Delta Sleep Inducing Peptide), also known as emideltide, is a peptide comprised of a short chain of 9 amino acids. Its primary research application is in inducing deep sleep, which is characterized by delta waves seen on an electroencephalogram (EEG).

What is DSIP used for?

DSIP is not currently approved as a prescription medication, but it has been studied in preclinical research. Areas of interest include: Insomnia; Withdrawal symptoms (alcohol and opioids); Chronic pain syndromes.

How does DSIP work?

DSIP appears to cross into the brain and CSF through active transport, where it may modulate neural activity in a state-dependent way — meaning its effects on sleep and EEG patterns can shift based on the individual’s baseline physiology.

What are the side effects of DSIP?

DSIP appears to be fairly well tolerated. Side effects may include mild heart rate variability, but this side effect is not well-documented.

What is the dosage of DSIP?

One commonly referenced research protocol is: Weeks 1-2: 0.2 mg (200 mcg) 30-60 minutes before bed; Weeks 3 and beyond: 0.5 mg (500 mcg) 30-60 minutes before bed. Shown for education only; a licensed clinician should set any actual dose. See the dosing table.

How do you mix (reconstitute) DSIP?

Wipe the vial tops with alcohol, add bacteriostatic water slowly so it runs down the inside of the glass, then roll the vial gently until the powder dissolves; don’t shake it. See the step-by-step guide with diagrams for the pen and syringe methods.

How much bacteriostatic water do you add to DSIP?

There is no single correct amount. We recommend 2.1 mL: about 0.1 mL is lost during transfer, leaving roughly 2.0 mL of usable solution. You can add more or less (most peptide vials hold up to 3 mL); just enter the amount in the dose calculator. See the step-by-step mixing guide.

Is DSIP FDA-approved?

No. DSIP is not FDA-approved in the US (status as of October 2026).

References

  1. Schneider-Helmert D, et al. Acute and delayed effects of DSIP (delta sleep-inducing peptide) on human sleep behavior. Int J Clin Pharmacol Ther Toxicol. 1981 Aug;19(8):341-5. View source
  2. Bes F, Hofman W, Schuur J, Van Boxtel C. Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients. A double-blind study. Neuropsychobiology. 1992;26(4):193-7. View source